Thousands of families are being wrongly and unfairly denied Government funding for their loved ones’ nursing care because of flaws in a system meant to help those with dementia. The NHS offers full ...
Abbott made one of the biggest deals in recent medtech history last week when it announced its plan to acquire Exact Sciences — maker of colon cancer screening test Cologuard — for $23 billion.
It is a potentially deadly health condition that plagues more than half of all British adults. High cholesterol causes a sticky form of fat to build up in the arteries, blocking blood flow. Left ...
In January, Exact Sciences CEO Kevin Conroy told us that 2025 was shaping up to be a transformative year for the diagnostics company. Three cancer test launches, multiple study readouts and one $23 ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Abbott Laboratories is making ...
Abbott announced Thursday morning that it is acquiring Exact Sciences for $21 billion. The deal values Exact Sciences at $105 per share, representing a 22% premium to the cancer screening company’s ...
Investing.com -- Shares of Exact Sciences are soaring over 21% on Wednesday following a Bloomberg report that Abbott Laboratories is in advanced talks to acquire the medical-testing company. According ...
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Exact Sciences (EXAS) one of those stocks right now? By taking a look at the ...
The healthcare diagnostics specialist posted its latest set of quarterly figures. This featured a surprise net profit, among other goodies. Just after market close on Monday, Exact Sciences took the ...
You may not get exact change back if you pay in cash on your next trip to McDonald's, the Chicago-based burger chain said. It's all because the United States is running out of pennies. Stream NBC 5 ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The accounting firm's managing ...
As Halloween approaches, Exact Sciences is warding off a particularly terrifying occurrence: skipping colorectal cancer screening. A newly launched campaign touts the company’s Cologuard test as a non ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results